ALPHA-FETOPROTEIN GLYCOSYLATION IS ABNORMAL IN SOME HEPATOCELLULAR CARCINOMAS, INCLUDING WHITE PATIENTS WITH A NORMAL ALPHA-FETOPROTEIN CONCENTRATION

被引:15
|
作者
AJDUKIEWICZ, AB
KELLEHER, PC
KRAWITT, EL
WALTERS, CJP
MASON, PB
KOFF, RS
BELANGER, L
机构
[1] UNIV VERMONT,COLL MED,DEPT MED,BURLINGTON,VT 05405
[2] MRC LABS,BANJUL,SENEGAMBIA
[3] UNIV VERMONT,COLL MED,DEPT PEDIAT,BURLINGTON,VT 05405
[4] METROWEST MED CTR,FRAMINGHAM,MA 01701
[5] UNIV LAVAL,CTR RECH CANCEROL,QUEBEC CITY G1R 2S6,PQ,CANADA
关键词
ALPHA-FETOPROTEIN; GLYCOSYLATION; TYROSINEMIA; CHRONIC HEPATITIS; HEPATOCELLULAR CARCINOMA;
D O I
10.1016/0304-3835(93)90042-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lectin-affinity analyses with Lens culinaris agglutinin (LCA) and other lectins have demonstrated that the glycosylation of alpha-fetoprotein (AFP) secreted by hepatocellular carcinomas (HCC) is frequently altered when the serum AFP concentration is increased. To determine if AFP LCA-binding properties are altered in patients with HCC whose serum AFP concentration is normal, the percentage of LCA-binding AFP in serum from white newborns, white normal adults, white patients with chronic hepatitis and hereditary tyrosinemia and white and black patients with HCC were determined. The serum LCA-binding AFP fraction was low in newborns (1-4%) and normal adults (1-8%). There was a significant increase in LCA-binding AFP in patients with chronic hepatitis (10-24%) and hereditary tyrosinemia (5-35%). The AFP LCA-binding fraction was clearly abnormal (greater than 40%) in three of the white patients with an HCC and a normal serum AFP concentration, and the range of values (10-63%) in these HCC patients was similar to that seen in both white and black patients with HCC accompanied by increased AFP concentrations.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [1] FUCOSYLATION OF ALPHA-FETOPROTEIN IN HEPATOCELLULAR CARCINOMAS
    BUAMAH, PK
    CORNELL, C
    CASSELLSSMITH, AJ
    HARRIS, AL
    [J]. LANCET, 1986, 1 (8486): : 922 - 923
  • [2] Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein
    Nouso, Kazuhiro
    Kobayashi, Yoshiyuki
    Nakamura, Shinichiro
    Kobayashi, Sayo
    Takayama, Hiroki
    Toshimori, Junichi
    Kuwaki, Kenji
    Hagihara, Hiroaki
    Onishi, Hideki
    Miyake, Yasuhiro
    Ikeda, Fusao
    Shiraha, Hidenori
    Takaki, Akinobu
    Iwasaki, Yoshiaki
    Kobashi, Haruhiko
    Yamamoto, Kazuhide
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (07) : 1195 - 1200
  • [3] Alpha-fetoprotein and hepatocellular carcinoma
    Colli, Agostino
    Fraquelli, Mirella
    Conte, Dario
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08): : 1939 - 1939
  • [4] SERUM ALPHA-FETOPROTEIN IN EXPERIMENTAL HEPATOCELLULAR CARCINOMAS IN RATS
    NAIDU, NRG
    AIKAT, BK
    DASH, RJ
    SEHGAL, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (03) : 295 - &
  • [5] Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
    Lee, Chao-Wei
    Tsai, Hsin-, I
    Lee, Wei-Chen
    Huang, Shu-Wei
    Lin, Cheng-Yu
    Hsieh, Yi-Chung
    Kuo, Tony
    Chen, Chun-Wei
    Yu, Ming-Chin
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [6] NORMAL BIOLOGY OF ALPHA-FETOPROTEIN
    GITLIN, D
    [J]. TRANSACTIONS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 36 (08): : 821 - 821
  • [7] NORMAL BIOLOGY OF ALPHA-FETOPROTEIN
    GITLIN, D
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 259 (AUG22) : 7 - 16
  • [8] ALPHA-FETOPROTEIN NORMAL VALUES
    CAGLAR, MK
    BAKKEREN, JAJM
    GEVEN, WB
    [J]. PEDIATRICS, 1989, 83 (04) : 640 - 640
  • [9] Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
    Wei, Zhewen
    Zhang, Yizhou
    Lu, Haizhen
    Ying, Jianming
    Zhao, Hong
    Cai, Jianqiang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) : 669 - 677
  • [10] ALPHA-FETOPROTEIN
    不详
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 38 (03) : 241 - 247